Current and historical daily PE Ratio for BHVN (
Biohaven Ltd
) from 2022 to Mar 21 2023. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Biohaven stock (BHVN) PE ratio as of Mar 21 2023 is 0.
More Details
Biohaven Ltd (BHVN) PE Ratio (TTM) Chart
Biohaven Ltd (BHVN) PE Ratio (TTM) Historical Data
View and export this data going back to 2022. Start your Free Trial
Total 123
- 1
- 2
| Biohaven PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2023-03-22 | At Loss | 2023-01-13 | At Loss |
| 2023-03-20 | At Loss | 2023-01-12 | At Loss |
| 2023-03-17 | At Loss | 2023-01-11 | At Loss |
| 2023-03-16 | At Loss | 2023-01-10 | At Loss |
| 2023-03-15 | At Loss | 2023-01-09 | At Loss |
| 2023-03-14 | At Loss | 2023-01-06 | At Loss |
| 2023-03-13 | At Loss | 2023-01-05 | At Loss |
| 2023-03-10 | At Loss | 2023-01-04 | At Loss |
| 2023-03-09 | At Loss | 2023-01-03 | At Loss |
| 2023-03-08 | At Loss | 2022-12-30 | At Loss |
| 2023-03-07 | At Loss | 2022-12-29 | At Loss |
| 2023-03-06 | At Loss | 2022-12-28 | At Loss |
| 2023-03-03 | At Loss | 2022-12-27 | At Loss |
| 2023-03-02 | At Loss | 2022-12-23 | At Loss |
| 2023-03-01 | At Loss | 2022-12-22 | At Loss |
| 2023-02-28 | At Loss | 2022-12-21 | At Loss |
| 2023-02-27 | At Loss | 2022-12-20 | At Loss |
| 2023-02-24 | At Loss | 2022-12-19 | At Loss |
| 2023-02-23 | At Loss | 2022-12-16 | At Loss |
| 2023-02-22 | At Loss | 2022-12-15 | At Loss |
| 2023-02-21 | At Loss | 2022-12-14 | At Loss |
| 2023-02-17 | At Loss | 2022-12-13 | At Loss |
| 2023-02-16 | At Loss | 2022-12-12 | At Loss |
| 2023-02-15 | At Loss | 2022-12-09 | At Loss |
| 2023-02-14 | At Loss | 2022-12-08 | At Loss |
| 2023-02-13 | At Loss | 2022-12-07 | At Loss |
| 2023-02-10 | At Loss | 2022-12-06 | At Loss |
| 2023-02-09 | At Loss | 2022-12-05 | At Loss |
| 2023-02-08 | At Loss | 2022-12-02 | At Loss |
| 2023-02-07 | At Loss | 2022-12-01 | At Loss |
| 2023-02-06 | At Loss | 2022-11-30 | At Loss |
| 2023-02-03 | At Loss | 2022-11-29 | At Loss |
| 2023-02-02 | At Loss | 2022-11-28 | At Loss |
| 2023-02-01 | At Loss | 2022-11-25 | At Loss |
| 2023-01-31 | At Loss | 2022-11-23 | At Loss |
| 2023-01-30 | At Loss | 2022-11-22 | At Loss |
| 2023-01-27 | At Loss | 2022-11-21 | At Loss |
| 2023-01-26 | At Loss | 2022-11-18 | At Loss |
| 2023-01-25 | At Loss | 2022-11-17 | At Loss |
| 2023-01-24 | At Loss | 2022-11-16 | At Loss |
| 2023-01-23 | At Loss | 2022-11-15 | At Loss |
| 2023-01-20 | At Loss | 2022-11-14 | At Loss |
| 2023-01-19 | At Loss | 2022-11-11 | At Loss |
| 2023-01-18 | At Loss | 2022-11-10 | At Loss |
| 2023-01-17 | At Loss | 2022-11-09 | At Loss |
Biohaven Ltd (BHVN) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Biohaven Ltd
NAICS : 541714
SIC : 2834
Description
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Its neuroscience portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7, glutamate receptors, myostatin, and TRP channels. Its products target diseases such as migraine, depression, bipolar, and schizophrenia.
